Quality control trial for human immunodeficiency virus type 1 drug resistance testing using clinical samples reveals problems with detecting minority species and interpretation of test results.
about
Low-abundance HIV drug-resistant viral variants in treatment-experienced persons correlate with historical antiretroviral usePrevalence of WHO transmitted drug resistance mutations by deep sequencing in antiretroviral-naïve subjects in Hunan Province, ChinaEstimating HIV-1 fitness characteristics from cross-sectional genotype dataStability of HIV-1 Nucleic Acids in Dried Blood Spot Samples for HIV-1 Drug Resistance GenotypingTREAT Asia Quality Assessment Scheme (TAQAS) to standardize the outcome of HIV genotypic resistance testing in a group of Asian laboratoriesDiscordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent.Characterizing the emergence and persistence of drug resistant mutations in HIV-1 subtype C infections using 454 ultra deep pyrosequencingConsensus drug resistance mutations for epidemiological surveillance: basic principles and potential controversies.Genotyping external quality assurance in the World Health Organization HIV drug resistance laboratory network during 2007-2010.HIV drug resistance testing by high-multiplex "wide" sequencing on the MiSeq instrument.Current landscape and new paradigms of proficiency testing and external quality assessment for molecular genetics.Dual-reporter phenotypic assay for human immunodeficiency virusesImpact of HIV drug resistance on virologic and immunologic failure and mortality in a cohort of patients on antiretroviral therapy in China.Capacity building and predictors of success for HIV-1 drug resistance testing in the Asia-Pacific region and Africa.Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.Low-frequency nevirapine (NVP)-resistant HIV-1 variants are not associated with failure of antiretroviral therapy in women without prior exposure to single-dose NVP.Detection of drug-resistant HIV minorities in clinical specimens and therapy failure.Development and evaluation of a national reference panel of HIV-1 protease and reverse transcriptase drug-resistance mutations for HIV-1 genotypic resistance assays in China.
P2860
Q28475651-ABDDF9A8-166D-40ED-B97C-2B7F613C57DCQ28539368-1B8D8969-A438-4360-A39A-D307E146B757Q28544753-BC754CB0-6F63-4786-8027-F54B65AB580EQ28546274-67C9AD05-5975-4E5F-9FF1-FC338946989FQ33824827-8D462E8C-AD72-4A43-ACD2-F757C87B2FD7Q34352000-9293271E-34C6-46B6-AE50-2140C9C7554BQ34567556-C07946B2-FB47-46A2-82BF-947DBD2D75C3Q35300021-7637F6A1-B03B-4461-B1A4-61D5D105A9B8Q35917555-7F373AE3-A525-40FD-92B9-E5EF00AE05B3Q36158371-92579EE5-4CA6-47FB-9308-4E0CDF7B98EBQ36384580-6CE07358-7F05-41A3-AFA1-77EAB545B10AQ36452419-F9ACFC62-16C1-4216-BC85-BDFFFFCC1422Q36959418-C4EFF236-10E3-42AB-A13C-07B0D72E4E50Q37005868-3185FF08-4F75-426F-99D8-2A095289EE85Q37189622-14753416-1EBD-4DF3-93F8-B55B197FCD5EQ37582339-2CFF08A4-F5B7-4727-B96C-5B25256E3F9CQ44750837-F528B3DF-09E4-4762-B061-62169182F6EEQ54695288-D69C9673-F070-4DAF-B31E-31AFBA0897D9
P2860
Quality control trial for human immunodeficiency virus type 1 drug resistance testing using clinical samples reveals problems with detecting minority species and interpretation of test results.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Quality control trial for huma ...... nterpretation of test results.
@ast
Quality control trial for huma ...... nterpretation of test results.
@en
type
label
Quality control trial for huma ...... nterpretation of test results.
@ast
Quality control trial for huma ...... nterpretation of test results.
@en
prefLabel
Quality control trial for huma ...... nterpretation of test results.
@ast
Quality control trial for huma ...... nterpretation of test results.
@en
P2093
P2860
P1476
Quality control trial for huma ...... nterpretation of test results.
@en
P2093
Barbara Schmidt
Hauke Walter
Heide Reil
Klaus Korn
P2860
P304
P356
10.1128/JCM.41.8.3559-3565.2003
P407
P577
2003-08-01T00:00:00Z